Dr. Cade W. Clark, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Oklahoma College of Medicine (2018)
- Years since graduation
- 8
- In the NPI registry since
- 2018
- Medicare patients seen, 2024
- 201
Licensed in Texas since 2021, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2018Medical school: University of Oklahoma College of Medicine
- 2018Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
TX license T3451 (first issued 2021; active) -
Internal Medicine Physician
TX license T3451 (first issued 2021; active) - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Christus Mother Frances Hospital Tyler, TX
- Ut Health East Texas Tyler Regional Hospital Tyler, TX
- Ut Health East Texas Athens Hospital Athens, TX
- University of Texas Health Science Center at Tyler Tyler, TX
- Ut Health East Texas Henderson Hospital Henderson, TX
Medical groups
- University of Texas Health Science Center at Tyler-Facilty-Physician (122 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 201
- Services billed
- 33,681
- Patients’ average age
- 74
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 19 companies reported 34 payments worth $773 in total to this clinician.
| AbbVie Inc. | $121 |
|---|---|
| Pfizer Inc. | $95.58 |
| Tempus Ai, Inc | $87.76 |
| Janssen Biotech, Inc. | $86.67 |
| AstraZeneca Pharmaceuticals LP | $42.84 |
| Aveo Pharmaceuticals, Inc. | $36.79 |
| Galvanize Therapeutics, Inc | $35.77 |
| Novartis Pharmaceuticals Corporation | $31.56 |
| Food and Beverage | $773 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.